These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4927145)

  • 1. Neuronal vascular relationships in the zona compacta of normal and parkinsonian substantia nigra.
    Issidorides MR
    Brain Res; 1971 Jan; 25(2):289-99. PubMed ID: 4927145
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.
    Sofic E; Paulus W; Jellinger K; Riederer P; Youdim MB
    J Neurochem; 1991 Mar; 56(3):978-82. PubMed ID: 1704426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromelanin in the substantia nigra of adult horses.
    Cozzi B; Pellegrini M; Droghi A
    Anat Anz; 1988; 166(1-5):53-61. PubMed ID: 3189848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells.
    Mann DM; Yates PO
    Brain; 1974 Sep; 97(3):489-98. PubMed ID: 4423478
    [No Abstract]   [Full Text] [Related]  

  • 6. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
    Damier P; Hirsch EC; Agid Y; Graybiel AM
    Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Key points in the neuropathological study of idiopathic parkinsonism].
    Shiraki H
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):874-96. PubMed ID: 4897052
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron and ferritin in substantia nigra in Parkinson's disease.
    Jellinger KA; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim MB; Ben-Shachar D
    Adv Neurol; 1993; 60():267-72. PubMed ID: 8420142
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.
    McGeer PL; Itagaki S; Boyes BE; McGeer EG
    Neurology; 1988 Aug; 38(8):1285-91. PubMed ID: 3399080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brain.
    Issidorides MR; Mytilineou C; Whetsell WO; Yahr MD
    Arch Neurol; 1978 Oct; 35(10):633-7. PubMed ID: 697603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron in the Parkinsonian substantia nigra.
    Gerlach M; Double K; Riederer P; Hirsch E; Jellinger K; Jenner P; Trautwein A; Youdim MB
    Mov Disord; 1997 Mar; 12(2):258-60. PubMed ID: 9087993
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.
    Gibb WR; Fearnley JM; Lees AJ
    Adv Neurol; 1990; 53():31-4. PubMed ID: 2173373
    [No Abstract]   [Full Text] [Related]  

  • 14. The pigment in the substantia nigra in parkinsonism. microspectrophotometric comparison with other sources of human pigment.
    Pakkenberg H
    Brain Res; 1966 Aug; 2(2):173-80. PubMed ID: 5968920
    [No Abstract]   [Full Text] [Related]  

  • 15. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the melanin of the substantia nigra].
    FRIEDE R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 218(4):286-9. PubMed ID: 13087360
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.
    Good PF; Olanow CW; Perl DP
    Brain Res; 1992 Oct; 593(2):343-6. PubMed ID: 1450944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian.
    Barcia C; Bautista V; Sánchez-Bahillo A; Fernández-Villalba E; Faucheux B; Poza y Poza M; Fernandez Barreiro A; Hirsch EC; Herrero MT
    J Neural Transm (Vienna); 2005 Sep; 112(9):1237-48. PubMed ID: 15666038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the fiber connection of the substantia nigra].
    Masuda S
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):839-44. PubMed ID: 5753734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.